Skip to content
Health | A twice-yearly shot could help end AIDS. But…
82°F
Sunday, August 24th 2025

e-Edition

Trending:

News
Health

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Nearly all of Latin America was excluded from the deal with drugmaker Gilead, sparking concern the world is missing a critical opportunity to stop AIDS.

FILE – A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug, at the Desmond Tutu Health Foundation’s Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024, which was one of the sites for Gilead’s lenacapavir drug trial. (AP Photo/Nardus Engelbrecht, File)
FILE – A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug, at the Desmond Tutu Health Foundation’s Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024, which was one of the sites for Gilead’s lenacapavir drug trial. (AP Photo/Nardus Engelbrecht, File)
Author
By
UPDATED:

Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop AIDS.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

Originally Published:

RevContent Feed

More in Health

Page was generated in 2.1917390823364